| Home
Registration
Schedule
Nano Stock Index
Nano Info links
Conference Team
Directions
|
Cédric Loiret-Bernal
 |
Cédric Loiret-Bernal,
M.D.
President and CEO
|
Cédric Loiret-Bernal, M.D., is president and chief executive officer as well as
a member of the board of directors of NanoInk, Inc. He joined the company in
October 2003. Dr. Loiret-Bernal is the former chief executive officer and
co-founder of GeneProt Inc., an industrial-scale proteomics company for which he
raised more than $150 million from institutional investors and corporate
partners such as Novartis, Compaq (now HP) and Bruker.
Dr. Loiret-Bernal joins NanoInk from CDP Capital Technology
Ventures, the largest Canadian institutional investor. At CDP, he was venture
advisor for life sciences investments in the U.S.
Prior to GeneProt, he was a partner and senior investment analyst at Brinson
Partners (now part of UBS Global Asset Management), an asset management division
with healthcare holdings in excess of $3 billion. He also held many other senior
positions in corporate strategic planning for Abbott Laboratories, in marketing
at Haemonetics and Porgès-Synthélabo.
Dr. Loiret-Bernal holds a doctor of medicine degree, summa cum laude, from the
University of Bordeaux and has an MBA degree from the J.L. Kellogg Graduate
School of Management, Northwestern University. |
